文献速递肿瘤 PET/CT

妇科肿瘤FDG PET/CT的变异与陷阱

PET/CT Variants and Pitfalls in Gynecological Cancers.
PubMed 文献 · Semin Nucl Med · 2021-07-10

本文综述了FDG PET/CT在妇科恶性肿瘤评估中的演变与标准应用,强调其在分期、疗效评估、复发监测及放疗计划中的作用,并指出FDG高敏感性但低特异性,需注意月经周期与绝经状态导致的生理性摄取变异及假阳性、假阴性陷阱。

要点

  • FDG PET/CT已用于妇科肿瘤分期、疗效评估、复发监测和放疗计划。
  • FDG对恶性肿瘤敏感性高但特异性低,炎症等良性病变也可高摄取。
  • 女性盆腔FDG摄取随月经周期和绝经状态变化,需识别生理性变异。

核心结论

  • FDG PET/CT在妇科恶性肿瘤评估中具有重要作用,但需熟悉盆腔常见良恶性变异与陷阱以辅助鉴别诊断。

研究设计与样本

  • 本文为综述,围绕FDG PET/CT在妇科恶性肿瘤中的应用与判读陷阱进行总结。

主要发现

  • FDG PET/CT用于妇科恶性肿瘤治疗前后评估及放疗计划中勾画代谢活跃的大体肿瘤体积。
  • FDG对恶性肿瘤敏感性高但特异性低,感染等炎症反应亦可表现为FDG高摄取。
  • 女性盆腔FDG摄取随月经周期和绝经状态变化,可造成判读困难。
  • 女性生殖系统偶发影像发现中,良恶性病变的假阳性和假阴性并不少见。
  • 宫颈癌是女性第四常见癌症,位列乳腺癌、结直肠癌和肺癌之后。

临床怎么用

  • 判读女性盆腔FDG PET/CT时应结合月经周期与绝经状态解释生理性摄取变异。
  • 需警惕炎症等良性FDG高摄取病变,避免误判为恶性。
  • 应熟悉妇科肿瘤常见良恶性变异与陷阱,以优化鉴别诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The role of hybrid imaging with 2-[18F] flourodeoxyglucose (FDG) positron emission tomography and computed tomography (PET/CT) is continuously evolving and now considered standard practice in evaluation of disease stage, treatment response, recurrent disease and follow-up for numerous primary malignancies. In gynecological malignancies FDG PET/CT plays an important role, not only in the assessment of disease in the pre-and post-therapy setting, but also in radiation therapy (RT) planning by defining the metabolically active gross tumor volume (GTV. The glucose analogue radiotracer, FDG, is by far the most utilized radiotracer in PET/CT and is typically seen with high uptake in malignant cells. The radiotracer FDG has a high sensitivity but low specificity for malignancy, as benign processes with an inflammatory response for example infection, are also FDG-avid. In the evaluation of the female pelvic region an awareness of potential confounding factors in the interpretation of FDG is essential as variations of FDG uptake occur in accordance with the menstrual cycle and the menopausal state. Incidental imaging findings in the female genital can pose differential diagnostic challenges as false-positive and false-negative findings in benign and malignant processes are not uncommon. Gynecological malignancies continue to pose major public health problems with cervical cancer as the fourth most common cancer in women ranking after breast cancer, colorectal cancer and lung cancer. Familiarity with frequently encountered benign and malignant variants and pitfalls in FDG PET/CT in the female pelvic region can aid the reader in differential diagnostic considerations.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Dejanovic D, Hansen NL, Loft A, et al. PET/CT Variants and Pitfalls in Gynecological Cancers. Semin Nucl Med. 2021. PMID: 34253332. doi:10.1053/j.semnuclmed.2021.06.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。